Search Results - "Angstreich, Greg R."

Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors by Angstreich, Greg R., Matsui, William, Huff, Carol Ann, Vala, Milada S., Barber, James, Hawkins, Anita L., Griffin, Constance A., Douglas Smith, B., Jones, Richard J.

“…Summary Imatinib has impressive activity against chronic myeloid leukaemia (CML), but does not appear to completely eradicate the disease. Although responses…”
Get full text

Treatment options for chronic myeloid leukemia: imatinib versus interferon versus allogeneic transplant by Angstreich, Greg R, Smith, B Douglas, Jones, Richard J

“…PURPOSE OF REVIEWThis review considers recent developments in the treatment of chronic myeloid leukemia with attention to current data evaluating the relative…”
Get full text

Chronic Myeloid Leukemia Stem Cells and Their Differentiated Progeny Display Divergent Drug Sensitivities to Imatinib Mesylate and Interferon-Alpha by Matsui, William, Angstreich, Greg R., Vala, Milada S., Barber, James P., Hawkins, Anita L., Griffin, Constance A., Huff, Carol Ann, Smith, B. Douglas, Jones, Richard J.

“…Imatinib has largely replaced interferon-alpha (IFN) as front-line therapy in the treatment of chronic myeloid leukemia (CML) because of its favorable toxicity…”
Get full text